Educational Objectives:
1) Understand recent changes to the accreditation process and how to fully comply with CAAHEP Standards and Guidelines, the Curriculum and Entry-Level Competencies; using best practice examples, tools and CPRC-provided guidance (focusing on current challenges faced by programs, institutions, and educators)
2) Understand the relationship of the findings and recommendations of the Educators' Forum Task Forces and the Future of Cytopathology Summit on the Standards/Guidelines, the curriculum, and the overall program review and accreditation process
3) Discuss how legislative and regulatory issues and emerging technologies are affecting the profession, with the further evolution of now needed educational opportunities pertinent to the practice of cytotechnology
4) Outline opportunities for collaboration among communities of interest pertinent to the practice of cytopathology, discussing sponsorship, responsibility for accreditation oversight, and roles of site visitors
The practice and scope of cytotechnology is actively being redefined with education models and curricula currently evolving, a process that will most certainly deepen and accelerate with the final reports of the Task Forces of the 2009 Educators' Forum and the recent Future of Cytopathology Summit. As such, it is imperative for educators to have the appropriate information and tools necessary to ensure that all implemented changes remain compliant with accreditation Standards. As an integral component of this process, the Standards/Guidelines, curriculum and entry-level competencies are currently under review and revision. In this presentation and discussion, the Cytotechnology Programs Review Committee (CPRC) will provide guidance, tools and strategies for adapting to current practice model changes while maintaining compliance. Discussion will further focus on the role of professional organizations in cytotechnology education, challenges faced by existing education programs, and determination of next steps for future collaboration among communities of interest. Best practices of other CAAHEP accredited programs will be offered as examples and serve as points of discussion and debate.

Educational Objectives:
1) Understand the use and limitation of cytology in the diagnosis of lung cancer
2) Be familiar with the immunocytochemical stains necessary to distinguish adenocarcinoma from squamous cell carcinoma
3) Learn what molecular studies are necessary for the complete assessment of adenocarcinoma of the lung
The division of lung cancer into small cell and non-small cell subtypes in pathology is no longer sufficient. The pathologist must work closely with the clinician and understand the necessary sub-typing of lung carcinoma and the molecular studies that will determine treatment. The role of cytology in this setting is vital and participant will learn the tools and techniques needed to maximize the information that may be obtained using cytologic material.

1) Identify the role and modalities of a well conducted Performance Appraisal in the current business era
2) Effectively integrate CLIA's requirements in the Cytotechnologist Performance Appraisal
3) Address the integration of QC parameters for the use of semi-automated screening devices into the evaluation
4) Integrate histology and molecular biology correlative parameters for a more objective evaluation
5) Implement ideas for remediation
This roundtable discussion intends to discuss the application of objective methods for the performance appraisal of cytotechnologists in an era of paradigm shift, from screening to diagnosing and interpreting molecular biology test results.

Educational Objectives:
1) Review architectural and sub-cellular criteria for diagnosing cancer. A broad range of epithelial, soft tissue, and hematopoietic tumors will illustrate common architectural and sub-cellular criteria of malignancy
2) Review the known Cell Biology basis for the criteria illustrated in Objective 1. Anoikis and alteration in basal-apical polarity will be discussed in relation to architectural criteria. Genetic instability, nuclear lamina organization, nucleoli, and chromatin structure will be described in relation to sub-cellular criteria
3) Practical applications of cell biology to cytology will be discussed
Cytologists and cell biologists are both focused on cancer cells, yet there is very little cross-talk between these two fields. This session aims to create common ground through an in-depth description of the cell biology basis of cytologists’ criteria of malignancy. This session will be useful for cytologists who wish to collaborate or work in cancer research, and for educators who want to stay abreast of the rapid developments in research related to cytology. In addition to facilitating communication and collaboration, it is our experience that an understanding of the cell biology basis for morphologic changes helps reinforce a thorough understanding of the criteria of malignancy. This session therefore should have appeal for cytologists at all levels of experience—from beginners who want to learn or reinforce diagnostic concepts to senior cytologists who want to know the latest developments in the histone code or anoikis mechanisms. The session would also be useful for cell biologists who may wish to learn the diagnostic significance of various cell structural changes. At the end of the session, the audience members will be able to specify at least 6 distinct structural alterations of tumor cells and describe their cell biology basis.